Eli Lilly's nationwide insulin pricing settlement called off

By Reuters
| April 16, 2024

The decision to drop the deal came after U.S. District Judge Brian Martinotti refused to certify a class in the litigation, which also targets insulin drug makers Novo Nordisk and Sanofi.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...